-
1
-
-
33745130668
-
The pathophysiology of psoriasis
-
Barker JNWN (1991) The pathophysiology of psoriasis. Br J Dermatol 119: 445-61
-
(1991)
Br J Dermatol
, vol.119
, pp. 445-461
-
-
Barker, J.N.W.N.1
-
2
-
-
8244228685
-
Treatment of psoriasis with intermittent short course cyclosporin (Neoral). A multicentre study
-
Berth-Jones J, Henderson CA, Munro CS et al (1997) Treatment of psoriasis with intermittent short course cyclosporin (Neoral). A multicentre study. Br J Dermatol 136: 527-30
-
(1997)
Br J Dermatol
, vol.136
, pp. 527-530
-
-
Berth-Jones, J.1
Henderson, C.A.2
Munro, C.S.3
-
4
-
-
0028286895
-
Treatment of psoriasis by topical photodynamic therapy with polychromatic light
-
Boehncke WH, Sterry W, Haufman R (1994) Treatment of psoriasis by topical photodynamic therapy with polychromatic light. Lancet 343: 801
-
(1994)
Lancet
, vol.343
, pp. 801
-
-
Boehncke, W.H.1
Sterry, W.2
Haufman, R.3
-
5
-
-
0029155801
-
Inhibition of the metabolism of endogenous retinoic acid as treatment for severe psoriasis an open study with oral liarozole
-
Dockx D, Decree J, Degreef H (1995) Inhibition of the metabolism of endogenous retinoic acid as treatment for severe psoriasis an open study with oral liarozole. Br J Dermatol 133: 426-32
-
(1995)
Br J Dermatol
, vol.133
, pp. 426-432
-
-
Dockx, D.1
Decree, J.2
Degreef, H.3
-
7
-
-
0030002445
-
Systemic tacrolimus (FK506) is effective for the treatment of psoriasis in a double-blind, placebo controlled study
-
European FK506 Multicentre Psoriasis Study Group (1996) Systemic tacrolimus (FK506) is effective for the treatment of psoriasis in a double-blind, placebo controlled study. Arch Dermatol 136: 419-23
-
(1996)
Arch Dermatol
, vol.136
, pp. 419-423
-
-
-
8
-
-
0025244112
-
Validation of sickness impact profile and psoriasis disability index in psoriasis
-
Finlay AY, Khan GK, Lascombe D et al (1990) Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol 123: 751-6
-
(1990)
Br J Dermatol
, vol.123
, pp. 751-756
-
-
Finlay, A.Y.1
Khan, G.K.2
Lascombe, D.3
-
9
-
-
0023720550
-
Psoriasis
-
Fry L (1988) Psoriasis. Br J Dermatol 119: 445-61
-
(1988)
Br J Dermatol
, vol.119
, pp. 445-461
-
-
Fry, L.1
-
12
-
-
0028990380
-
Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggest a primary immune, but not keratinocyte, pathogenic basis
-
Gottlieb SL, Gilleaudeau P, Johnson R et al (1995) Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggest a primary immune, but not keratinocyte, pathogenic basis. Nature Med 1: 442-7
-
(1995)
Nature Med
, vol.1
, pp. 442-447
-
-
Gottlieb, S.L.1
Gilleaudeau, P.2
Johnson, R.3
-
13
-
-
33745168582
-
Calcipotriene treatment of psoriasis results in an early induction of interleukin-10 and a concomitant reduction in interleukin-8 level
-
Kang S, Choi J-H, Yi S et al (1996) Calcipotriene treatment of psoriasis results in an early induction of interleukin-10 and a concomitant reduction in interleukin-8 level. Br J Dermatol 135(5): 836
-
(1996)
Br J Dermatol
, vol.135
, Issue.5
, pp. 836
-
-
Kang, S.1
Choi, J.-H.2
Yi, S.3
-
15
-
-
0024822201
-
Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC903)
-
Kragballe K (1989) Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC903). Arch Dermatol 125: 1647-52
-
(1989)
Arch Dermatol
, vol.125
, pp. 1647-1652
-
-
Kragballe, K.1
-
16
-
-
0029784520
-
A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis
-
Lebwohl M, Siskin SB, Epinette W et al (1996) A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis. J Am Acad Dermatol 35: 268-9
-
(1996)
J Am Acad Dermatol
, vol.35
, pp. 268-269
-
-
Lebwohl, M.1
Siskin, S.B.2
Epinette, W.3
-
17
-
-
0013600514
-
CTLA41g (BMS-188667)-mediated blockade of T Cell costimulation in patients with psoriasis vulgaris
-
Lebwohl M, Kang S, Guzzo C et al (1997) CTLA41g (BMS-188667)-mediated blockade of T Cell costimulation in patients with psoriasis vulgaris. J Invest Dermatol 108: 570
-
(1997)
J Invest Dermatol
, vol.108
, pp. 570
-
-
Lebwohl, M.1
Kang, S.2
Guzzo, C.3
-
18
-
-
0026588246
-
Immunosuppressive macrolides of the type FK506: A novel class of topical agents for treatment of skin diseases?
-
Meingassner JG, Stutz A (1992) Immunosuppressive macrolides of the type FK506: a novel class of topical agents for treatment of skin diseases? J Invest Dermatol 98: 851-5
-
(1992)
J Invest Dermatol
, vol.98
, pp. 851-855
-
-
Meingassner, J.G.1
Stutz, A.2
-
20
-
-
0025735332
-
Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasis?
-
Poizot-Martin I, Dhiver C, Mawas M et al (1991) Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasis? Lancet 337: 1477
-
(1991)
Lancet
, vol.337
, pp. 1477
-
-
Poizot-Martin, I.1
Dhiver, C.2
Mawas, M.3
-
22
-
-
0029857629
-
Tacalcitol ointment in the treatment of psoriasis vulgaris: A multicentre, placebo-controlled, double-blind study on efficacy and safety
-
Van de Kerkhof PCM, Haustein UF, Luger T et al (1996) Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety. Br J Dermatol 135: 758-65
-
(1996)
Br J Dermatol
, vol.135
, pp. 758-765
-
-
Van De Kerkhof, P.C.M.1
Haustein, U.F.2
Luger, T.3
-
23
-
-
0029848032
-
A novel dithranol formulation (Micanol): The effects of monotherapy and UVB combination therapy on epidermal differentiation, proliferation and cutaneous inflammation in psoriasis vulgaris
-
Van der Vleuten CJ, Gerritsen MJ, De Jong EM et al (1996) A novel dithranol formulation (Micanol): the effects of monotherapy and UVB combination therapy on epidermal differentiation, proliferation and cutaneous inflammation in psoriasis vulgaris. Acta Derm Venereol 76: 387-91
-
(1996)
Acta Derm Venereol
, vol.76
, pp. 387-391
-
-
Van Der Vleuten, C.J.1
Gerritsen, M.J.2
De Jong, E.M.3
|